Trump Signs Executive Order To Fast-Track Psychedelic Research
President Donald Trump signed an executive order aimed at accelerating clinical research and federal approval for psychedelic therapies especially ibogaine as mental health therapy for veterans. The post Trump Signs Executive Order To Fast-Track Psychedelic Research first appeared on Lucid News. The post Trump Signs Executive Order To Fast-Track Psychedelic Research appeared first on Lucid News.
External link. We are not responsible for the content.
Read more ↗More From Lucid News
Evaluating the Pros and Cons of State Psychedelic Task Forces
While state legislatures across the U.S. are creating task forces to evaluate proposed legislation to regulate psych...
New Orleans Hosts Psychedelic Research Conference Double-Header
Over the last week in February, more than 200 people from psychedelic drug development companies, clinical researcher...
Turning On The Culture
Author and therapist Charles Wininger asks what would happen if millions of people across the political spectrum aros...
Latest News
Whitehouse Directs FDA, HHS and VA to Expand Psychedelic Research Pathways
The White House moved to accelerate federal handling of psychedelic drugs, including ibogaine, while leaving core app...
Can an LLM get high? 5 Questions with clinical neuroscientist Ziv Ben-Zion
Ben-Zion discusses how artificial intelligence mimics the psychedelic experience.
5 Things We Learned at Psychedelic Culture 2026
Plus, ketamine addiction, DMT lasers, and plant medicine faeries [...] Read More... The post 5 Things We Learned at P...
Global Altered States: The Storefront Psychedelic
This week’s Sunday Insider: inside a storefront where Psychedelics are no longer a journey…they’re a choice.
Psychonautisme, Herbes et Suppléments
De nombreux aliments et compléments alimentaires courants contiennent des composés actifs qui interagissent avec la n...
MAPS Welcomes Federal Action to Advance Science-Driven Psychedelic Research and Policy
April 18, 2026 — The Multidisciplinary Association for Psychedelic Studies (MAPS) issued the following statements fro...